Talybov, Rustam,
Beylerli, Ozal,
Mochalov, Vadim,
Prokopenko, Alexey,
Ilyasova, Tatiana,
Trofimova, Tatiana,
Sufianov, Albert,
Guang, Yang (2022) ). Additionally, immunohistochemical
analysis was carried out with the following markers: CD3, CD20, CD34, Ki-67
Bai, Ming,
Wang, Xiaolong,
Zhang, Huixue,
Wang, Jianjian,
Lyaysan, Gaysina,
Xu, Si,
Tian, Kuo,
Wang, Tianfeng,
Li, Jie,
Wang, Na,
Lu, Xiaoyu,
Zhang, Xiaoming,
Wang, Lihua (2022) in prognosis
analysis, highlighting the role of the subclonal mutation in glioma prognosis. © 2022 Ming Bai et
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) -sequencing assay. Gene set enrichment
analysis of the RNA-seq data indicated that MD2 knockout was associated
Shnayder, N.A.,
Novitsky, M.A.,
Neznanov, N.G.,
Limankin, O.V.,
Asadullin, A.R.,
Petrov, A.V.,
Dmitrenko, D.V.,
Narodova, E.A.,
Popenko, N.V.,
Nasyrova, R.F. (2022) out research and
analysis of publications in the databases PubMed, Springer, Wiley Online Library
for IS diagnosis and treatment. Conclusions: Our
analysis provides a snapshot of the current scenario regarding
Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) from the ccRCC association
analysis. The final weighted and unweighted PGS models were based on 21 SNPs
Meshcheryakova, S.,
Shumadalova, A.,
Beylerli, O.,
Gareev, I.,
Zhao, S.,
Wu, J. (2022) with the results of structure activity relationship
analysis (MIC 0.1–10 μg/ml). © 2021 Wiley Periodicals, LLC.